Flexor Injury Rehabilitation Splint Trial (FIRST): protocol for a pragmatic randomised controlled trial comparing three splints for finger flexor tendon repairs

• Published in: Current controlled trials in cardiovascular medicine Vol. 25; no. 1; p. 193
• Main Authors: Bamford, Emma, Berntsson, Hannah, Beale, Suzanne, Desoysa, Lauren, Dias, Joseph, Hamer-Kiwacz, Sienna, Hind, Daniel, Johnson, Nick, Loban, Amanda, Molloy, Kaye, Morvan, Emma, Rombach, Ines, Selby, Anna, Thokala, Praveen, Turtle, Chris, Walters, Stephen, Drummond, Avril
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.03.2024; BioMed Central; BMC
• Subjects: Biosensors; Clinical medicine; Cost analysis; Finger flexor tendon repair; Finger flexor tendon rupture; Fingers; Hand therapy; Health aspects; Humans; Informed consent; Injuries; Joint Diseases; Multicenter Studies as Topic; Patient outcomes; Patients; Physical therapy; Physiotherapy; Pragmatic Clinical Trials as Topic; Quality of Life; Randomized Controlled Trials as Topic; Rehabilitation; Splinting; Splints; Splints (Surgery); Surgery; Tendon Injuries - diagnosis; Tendon Injuries - surgery; Tendons; Tendons - surgery; Therapeutics, Physiological; Treatment Outcome; United Kingdom; United Kingdom > UK; Hand therapy; Surgery; Physiotherapy; Randomised controlled trial; Splinting; Occupational therapy; Finger flexor tendon repair; Finger flexor tendon rupture; Rehabilitation
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-024-08013-z

Without surgical repair, flexor tendon injuries do not heal and patients' ability to bend fingers and grip objects is impaired. However, flexor tendon repair surgery also requires optimal rehabilitation. There are currently three custom-made splints used in the rehabilitation of zone I/II flexor tendon repairs, each with different assumed harm/benefit profiles: the dorsal forearm and hand-based splint (long), the Manchester short splint (short), and the relative motion flexion splint (mini). There is, however, no robust evidence as to which splint, if any, is most clinical or cost effective. The Flexor Injury Rehabilitation Splint Trial (FIRST) was designed to address this evidence gap. FIRST is a parallel group, superiority, analyst-blind, multi-centre, individual participant-randomised controlled trial. Participants will be assigned 1:1:1 to receive either the long, short, or mini splint. We aim to recruit 429 participants undergoing rehabilitation following zone I/II flexor tendon repair surgery. Potential participants will initially be identified prior to surgery, in NHS hand clinics across the UK, and consented and randomised at their splint fitting appointment post-surgery. The primary outcome will be the mean post-randomisation score on the patient-reported wrist and hand evaluation measure (PRWHE), assessed at 6, 12, 26, and 52 weeks post randomisation. Secondary outcome measures include blinded grip strength and active range of movement (AROM) assessments, adverse events, adherence to the splinting protocol (measured via temperature sensors inserted into the splints), quality of life assessment, and further patient-reported outcomes. An economic evaluation will assess the cost-effectiveness of each splint, and a qualitative sub-study will evaluate participants' preferences for, and experiences of wearing, the splints. Furthermore, a mediation analysis will determine the relationship between patient preferences, splint adherence, and splint effectiveness. FIRST will compare the three splints with respect to clinical efficacy, complications, quality of life and cost-effectiveness. FIRST is a pragmatic trial which will recruit from 26 NHS sites to allow findings to be generalisable to current clinical practice in the UK. It will also provide significant insights into patient experiences of splint wear and how adherence to splinting may impact outcomes. ISRCTN: 10236011.